GW Pharmaceuticals - GWPH

(Tom La Vallin) #1

GW Pharmaceuticals (Ticker GWPH) is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, for treatment of epilepsy was approved for treatment of epilepsy in 2018.


Absolutely got to agree with this, MMJ medical Marijuana is taking off! Now is a good time to invest …


I would certainly be interested in this one. Will give it a vote when I can :+1: